BC
GMAB icon

Brinker Capital’s Genmab GMAB Stock Holding History

Brinker Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-48,381
Closed -$1.02M – 955
2020
Q1 		$1.02M Sell
48,381
-1,670
-3% -$37.2K 0.04% 422
2019
Q4 		$1.12M Buy
50,051
+1,291
+3% +$28.2K 0.03% 467
2019
Q3 		$988K Buy
+48,760
New +$960K 0.03% 485

Other funds holding GMAB

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Brinker Capital's GMAB Position: Q2 2020 in Review

Brinker Capital sold out of Genmab (GMAB) in Q2 2020, closing a stake of 48,381 shares — an estimated $1.02M sold.

Brinker Capital first reported a position in GMAB in Q3 2019 and held it in 3 quarters. The position peaked at $1.12M in Q4 2019. 175 funds tracked by Wall St. Rank hold GMAB as of Q2 2020.

  • Brinker Capital reported no remaining Genmab position as of Q2 2020 after selling out during the quarter.
  • Brinker Capital sold 48,381 Genmab shares in Q2 2020, an estimated $1.02M.
  • Brinker Capital first reported a position in Genmab in Q3 2019 and held it in 3 quarters.
  • Brinker Capital's Genmab position peaked at $1.12M in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Genmab as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.